vs
Side-by-side financial comparison of BT Brands, Inc. (BTBD) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
BT Brands, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.2M, roughly 1.7× Instil Bio, Inc.). BT Brands, Inc. runs the higher net margin — 23.7% vs -365.3%, a 389.1% gap on every dollar of revenue. On growth, BT Brands, Inc. posted the faster year-over-year revenue change (-11.4% vs -19.2%).
BT Brands, Inc.BTBDEarnings & Financial Report
BT Group plc is a British multinational telecommunications holding company headquartered in London, England. It has operations in around 180 countries and is the largest provider of fixed-line, broadband and mobile services in the UK, and also provides subscription television and IT services.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
BTBD vs TIL — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $2.2M |
| Net Profit | $915.0K | $-8.2M |
| Gross Margin | — | — |
| Operating Margin | 19.1% | -426.3% |
| Net Margin | 23.7% | -365.3% |
| Revenue YoY | -11.4% | -19.2% |
| Net Profit YoY | 516.9% | 31.1% |
| EPS (diluted) | $0.15 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.2M | ||
| Q3 25 | $3.9M | $2.2M | ||
| Q2 25 | $3.8M | $2.2M | ||
| Q1 25 | $3.2M | $2.2M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | $4.3M | $1.5M | ||
| Q2 24 | $4.1M | $0 | ||
| Q1 24 | $3.2M | $0 |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | $915.0K | $-13.6M | ||
| Q2 25 | $55.0K | $-21.4M | ||
| Q1 25 | $-329.8K | $-28.2M | ||
| Q4 24 | — | $-11.9M | ||
| Q3 24 | $-219.5K | $-23.0M | ||
| Q2 24 | $-70.0K | $-14.9M | ||
| Q1 24 | $-445.7K | $-24.3M |
| Q4 25 | — | -426.3% | ||
| Q3 25 | 19.1% | -670.0% | ||
| Q2 25 | -2.0% | -1045.5% | ||
| Q1 25 | -9.0% | -1363.2% | ||
| Q4 24 | — | -426.1% | ||
| Q3 24 | -1.7% | -1582.8% | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -19.8% | — |
| Q4 25 | — | -365.3% | ||
| Q3 25 | 23.7% | -606.0% | ||
| Q2 25 | 1.5% | -954.2% | ||
| Q1 25 | -10.2% | -1257.8% | ||
| Q4 24 | — | -428.8% | ||
| Q3 24 | -5.0% | -1541.9% | ||
| Q2 24 | -1.7% | — | ||
| Q1 24 | -14.0% | — |
| Q4 25 | — | $-1.13 | ||
| Q3 25 | $0.15 | $-2.01 | ||
| Q2 25 | — | $-3.24 | ||
| Q1 25 | — | $-4.32 | ||
| Q4 24 | — | $-1.82 | ||
| Q3 24 | $-0.04 | $-3.54 | ||
| Q2 24 | — | $-2.29 | ||
| Q1 24 | — | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.7M | $113.9M |
| Total Assets | $11.9M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.6M | ||
| Q3 25 | $3.5M | $5.8M | ||
| Q2 25 | $3.0M | $7.7M | ||
| Q1 25 | $2.7M | $15.4M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | $2.0M | $6.7M | ||
| Q2 24 | $1.5M | $6.8M | ||
| Q1 24 | $1.5M | $5.5M |
| Q4 25 | — | $113.9M | ||
| Q3 25 | $7.7M | $120.4M | ||
| Q2 25 | $6.8M | $131.7M | ||
| Q1 25 | $6.7M | $144.9M | ||
| Q4 24 | — | $169.4M | ||
| Q3 24 | $8.5M | $176.3M | ||
| Q2 24 | $8.7M | $195.0M | ||
| Q1 24 | $8.8M | $205.8M |
| Q4 25 | — | $203.5M | ||
| Q3 25 | $11.9M | $211.8M | ||
| Q2 25 | $11.2M | $231.0M | ||
| Q1 25 | $11.0M | $237.4M | ||
| Q4 24 | — | $263.6M | ||
| Q3 24 | $13.7M | $272.6M | ||
| Q2 24 | $14.0M | $294.3M | ||
| Q1 24 | $14.0M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $325.2K | $-7.1M |
| Free Cash FlowOCF − Capex | $261.8K | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | 0.36× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-7.1M | ||
| Q3 25 | $325.2K | $-10.6M | ||
| Q2 25 | $384.4K | $-14.8M | ||
| Q1 25 | $-306.7K | $-4.2M | ||
| Q4 24 | — | $-10.6M | ||
| Q3 24 | $129.3K | $-20.1M | ||
| Q2 24 | $82.5K | $-10.6M | ||
| Q1 24 | $-408.9K | $-14.4M |
| Q4 25 | — | — | ||
| Q3 25 | $261.8K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-431.1K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $50.4K | — | ||
| Q2 24 | $53.7K | — | ||
| Q1 24 | $-521.3K | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -13.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -16.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 1.8% | 0.0% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 3.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 6.98× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
